As shown in Table 1, high expression of NCOA5 was notably associated with the length of tumor (P<0.001), regional lymph node staging (P=0.005) and cancer staging (P=0.018), suggesting that NCOA5 positively modulates malignant progression of CRC. The gene discussed is NCOA5; the disease is neoplasm.